# AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

> **NCT06512259** · — · RECRUITING · sponsor: **AlloSource** · enrollment: 200 (estimated)

## Conditions studied

- Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy

## Interventions

- **OTHER:** AlloMend® Acellular Dermal Matrix allograft

## Key facts

- **NCT ID:** NCT06512259
- **Lead sponsor:** AlloSource
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-19
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06512259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06512259, "AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06512259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*